Wiza logo
Wiza logo
Get a demo
Get started for free

Kimberly Holloway - Email & Phone Number

Associate Director of Translational Oncology at Iterion Therapeutics

Kimberly Holloway is based out of Greater Houston and works at Iterion Therapeutics as Associate Director of Translational Oncology.

Kimberly Holloway's Contact Information

Kimberly Holloway's Personal email
k*****@gmai***.com
Valid
Latest update
October 29, 2025
Location
Greater Houston

Kimberly's current employer

Iterion Therapeutics logo

Iterion Therapeutics

Description
HQ Location
Houston, Texas, United States
Number of employees
11-50
Industry
Biotechnology Research
Latest update
May 1, 2024

Frequent questions about Kimberly Holloway

What company is Kimberly Holloway working for?
Kimberly Holloway works for Iterion Therapeutics.
What is Kimberly Holloway's function at Iterion Therapeutics?
Kimberly Holloway is Associate Director of Translational Oncology at Iterion Therapeutics.
Where is Kimberly Holloway based?
Kimberly Holloway is based out of Greater Houston.
What is Kimberly Holloway's personal email address?
Kimberly Holloway's personal email address is k*****@gmai***.com
Who are Kimberly Holloway's co-workers?
Kimberly Holloway's colleagues are Rahul Aras, Gowri Sukumar, Laura Mendez, Lu Han 韩路 PhD, Jonathan Northrup, Stephen Horrigan.
Find anyone's contact info.
Get 20 free email reveals

Kimberly's co-workers

Rahul Aras avatar
Rahul Aras
President & CEO
Gowri Sukumar avatar
Gowri Sukumar
Senior Director CMC And Regulatory Affairs
Laura Mendez avatar
Laura Mendez
HR & Operations Manager
Lu Han 韩路 PhD avatar
Lu Han 韩路 PhD
Board Observer
Jonathan Northrup avatar
Jonathan Northrup
Board Member
Stephen Horrigan avatar
Stephen Horrigan
Chief Scientific Officer
Wiza does not guarantee or claim any of the information found on this public directory to be 100% accurate or up to date.Information found here is gathered from a variety of online and offline sources.If you wish to exclude your personal data from this public directory please fill out the optout form.